Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT

OBJECTIVES: Preclinical and clinical studies suggested cardioprotective effects of metformin treatment. In the GIPS-III trial, 4 months of metformin treatment did not improve left ventricular ejection fraction in patients presenting with ST-elevation myocardial infarction (STEMI). Here, we report th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Res Cardiol
Asıl Yazarlar: Hartman, Minke H. T., Prins, Jake K. B., Schurer, Remco A. J., Lipsic, Erik, Lexis, Chris P. H., van der Horst-Schrivers, Anouk N. A., van Veldhuisen, Dirk J., van der Horst, Iwan C. C., van der Harst, Pim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2017
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696505/
https://ncbi.nlm.nih.gov/pubmed/28755285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00392-017-1140-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller